Citrus Oncology, Inc.

What Citrus Oncology, Inc. does

Citrus Oncology, Inc. is a privately held, Delaware-incorporated digital health company founded in 2024 by Dr. Aabid Shariff (CEO) and Dr. Afreen Shariff. The company targets a narrow but high-stakes bottleneck in oncology care: cancer patients on novel life-saving drugs who experience adverse events must typically wait 26-89 days to see specialists familiar with those side effects, leading to delayed treatment and preventable hospitalizations. Citrus addresses this gap by combining an Agentic AI triage layer with on-demand access to specialty physicians who understand cancer drug toxicities, delivered through an Intelligent Care Platform (web) and a Citrus Patient App (mobile).

The core technology stack is described as Agentic AI combined with on-demand specialty care, with named features including AI-based triage and fast physician access. The platform operates in a text modality, supports SMS and email communications with patients, and is positioned as HIPAA-aware alongside COPPA and CCPA compliance. Products are supported by an advisory network drawn from MSKCC, Duke, Harvard Medical School, Carnegie Mellon, Ohio State, Cleveland Clinic, Wilmot Cancer Institute, Stanford, Northwell Health, UnitedHealthCare, and Tempus AI.

The business model is a B2B2C healthcare services platform combining recurring enterprise contracts with consumer/patient access. Go-to-market is sales-led and enterprise-focused, targeting oncologists, health systems, academic medical centers, pharma companies, and payers via direct outreach, partnerships, and Request a Demo CTAs. The Duke Cancer Institute partnership (announced 2026-02-27) is the principal enterprise reference. The company operates on a quote-based pricing model with no publicly disclosed pricing, and is currently pre-revenue or sub-$1M with 1-10 employees, supported by accelerator participation (Techstars AI Health Baltimore, CancerX) and backers including BrightEdge (American Cancer Society), ScaleHealth, CareFirst BlueCross BlueShield, Healthworx, and Digital Health.

Name

Citrus Oncology, Inc.

Legal name

Citrus Oncology, Inc.

Website

https://citrusoncology.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

1–10 employees

Short description

Citrus Oncology is a digital health company that combines Agentic AI triage with on-demand specialty physician access to help cancer patients manage adverse events from novel drug therapies, serving patients, oncologists, health systems, pharma, and payers.

Ownership category

akta.pro rank

Product category

Oncology Digital Health Platform

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000), Services-Prepackaged Software (7372)

akta.pro primary industry

Oncology Telemedicine Platforms (HLALAGAH)

akta.pro secondary industry

Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)

Keywords

• Oncology care management
• Cancer adverse events
• Specialty telehealth platform
• AI clinical triage
• Patient care coordination

Headquarters

HQ city

Wilmington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Healthcare Services Platform: Citrus Oncology appears to generate revenue through a healthcare services platform model combining AI-powered triage and on-demand specialty care for cancer patients experiencing adverse events. The platform serves multiple payer types including health systems, pharma, and payers, suggesting a B2B2C revenue model.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Citrus Oncology provides an Intelligent Care Platform that combines Agentic AI with on-demand specialty physician access to help cancer patients manage adverse events from novel cancer treatments. The platform features AI-based triage and rapid physician access, compressing the typical 26–89 day wait time to see a specialist who understands cancer drug side effects into immediate access. It is delivered to enterprise buyers (health systems, oncologists, pharma, payers) via a subscription-based model, with patients accessing care through a dedicated mobile application.

Product overview

Citrus Oncology offers a unified Intelligent Care Platform that combines Agentic AI with on-demand specialty care services. The platform consists of the core Intelligent Care Platform (web-based) and the Citrus Patient App (mobile application). Both products work together to enable AI-based triage and fast access to physicians for cancer patients dealing with adverse events from treatments.

Differentiator

Problem solved

Functional benefit

Products and services

• Intelligent Care Platform An enterprise-grade platform that combines proprietary Agentic AI triage with on-demand specialty physician access to help cancer patients manage adverse events from novel treatments. Features AI-based triage and fast physician access, compressing typical 26–89 day specialist waits into immediate access. Sold to enterprise buyers including health systems, oncologists, pharma, and payers via subscription-based contracts.
• Citrus Patient App Mobile application available at app.getcitruscare.com that allows cancer patients to log in and access Citrus Oncology's care services, including AI-based triage and on-demand specialty physician consultations. Serves as the patient-facing delivery channel for the enterprise Intelligent Care Platform.

Quantifiable outcome

• Reduces specialist wait time from 26-89 days to immediate access

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Duke Cancer InstitutecoreStrategic or Co-development Partner · 27 February 2026Duke Cancer Institute has partnered with Citrus Oncology for targeted care coordination and adverse event management in cancer treatment. The partnership focuses on privacy options and data handling related to patient care services. This represents a significant academic medical center reference customer.
• CancerXminorGTM or Marketing PartnerListed as a supporter/backer, CancerX appears to be a consortium or initiative supporting cancer care innovation.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Natera: Oncology-focused molecular diagnostics and MRD/monitoring company with growing patient-facing and provider-facing digital tools. Comparable oncology specialization and stakeholder breadth, though diagnostics-led rather than telehealth-led.
• Cohere Health: AI-powered prior authorization and clinical decision support platform working with payers and providers. Comparable as an AI clinical workflow company selling into health plans and providers, though its focus is authorization rather than oncology symptom triage.
• Tempus AI: AI-powered precision medicine company in oncology with data and clinical decision support offerings. An advisor firm relationship exists with Citrus. Broader incumbent that could move downstream into adverse event management.
• Flatiron Health: Oncology-focused electronic health record, data, and clinical workflow company (Roche subsidiary). Broad incumbent serving oncologists and life sciences companies; comparable customer base though focused on EHR/data rather than patient-facing adverse event triage.

Direct peers

• Thyme Care: Oncology-focused care navigation and telehealth platform that partners with payers and oncologists to manage cancer patients' symptoms and adverse events. Directly comparable to Citrus in serving the same adverse-event-management use case with multi-stakeholder B2B2C monetization.
• Jasper Health: Digital oncology care platform offering symptom management, care navigation, and psychosocial support to cancer patients. Direct peer in oncology symptom monitoring and care coordination, with similar payer and provider GTM motions.
• VivorCare: Oncology supportive care platform providing virtual supportive care and side-effect management for cancer patients. Closely overlaps Citrus's on-demand specialty care and AI-assisted triage for adverse event management.
• OncoHealth: Virtual cancer care company delivering oncology-specific telehealth, symptom management, and care navigation to health plans and providers. Comparable in oncology-focused virtual specialty care with payer and provider business model.

Emerging players

• Memora Health: AI-driven patient engagement and care navigation platform with strong oncology workflows. Comparable as an AI agent platform for symptom monitoring and care coordination, though broader than oncology-only.
• Color Health: Cancer-focused virtual care and genetic testing platform with AI-enabled clinical workflows. Comparable in combining oncology care delivery with technology-enabled triage and AI tooling.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/citrus-oncology

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Citrus Oncology, Inc.